INBIOSE N V has a total of 24 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, foods and drinks and organic fine chemistry are NANJING LANGEN BIOLOGICAL SCIENCE & TECH CO LTD, CYSBIO APS and YUKAWA HIDEAKI.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Australia | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Foods and drinks | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Fermentation | |
#3 | Peptides | |
#4 | Enzymes | |
#5 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Beauprez Joeri | 22 |
#2 | Vercauteren Annelies | 9 |
#3 | Maertens Jo | 9 |
#4 | Peters Gert | 8 |
#5 | Coussement Pieter | 8 |
#6 | Van Herpe Dries | 7 |
#7 | De Mey Marjan | 5 |
#8 | Lequeux Gaspard | 4 |
#9 | De Maeseneire Sofie | 4 |
#10 | Lannoo Nausicaä | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021074182A1 | Production of bioproduct in a host cell | |
WO2021013708A1 | Production of fucosyllactose in host cells | |
WO2020245320A1 | Optimal chromosomal insertion loci | |
WO2020127417A2 | PRODUCTION OF 3-FUCOSYLLACTOSE AND LACTOSE CONVERTING α-1,3-FUCOSYLTRANSFERASE ENZYMES | |
CA3048521A1 | In vivo synthesis of sialylated compounds | |
AU2015215937A1 | Metabolically engineered organisms for the production of added value bio-products |